Literature DB >> 21681589

Angiogenesis in unknown primary tumors.

Vito Longo, Angelo Vacca, Domenico Ribatti.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21681589     DOI： 10.1007/s10238-011-0145-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN： 1591-8890            Impact factor:   3.984


× No keyword cloud information.
  10 in total

1.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  Morphological and molecular aspects of physiological vascular morphogenesis.

Authors:  Domenico Ribatti; Beatrice Nico; Enrico Crivellato
Journal:  Angiogenesis       Date:  2009-01-07       Impact factor: 9.596

3.  Microvessel density in unknown primary tumors.

Authors:  H F Hillen; L E Hak; S R Joosten-Achjanie; J W Arends
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

Review 4.  Bone marrow angiogenesis in multiple myeloma.

Authors:  A Vacca; D Ribatti
Journal:  Leukemia       Date:  2006-02       Impact factor: 11.528

5.  Matrix metalloproteinases in carcinoma of unknown primary.

Authors:  Vasilis Karavasilis; Vasiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Haralambos Kalofonos; George Fountzilas; Theodore Fotsis; Nicholas Pavlidis
Journal:  Cancer       Date:  2005-11-15       Impact factor: 6.860

6.  Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.

Authors:  John D Hainsworth; David R Spigel; Cindy Farley; Dana S Thompson; Dianna L Shipley; F Anthony Greco
Journal:  J Clin Oncol       Date:  2007-05-01       Impact factor: 44.544

7.  Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.

Authors:  John D Hainsworth; David R Spigel; Dana S Thompson; Patrick B Murphy; Cassie M Lane; David M Waterhouse; Yuval Naot; F Anthony Greco
Journal:  Oncologist       Date:  2009-12-04

Review 8.  Angiogenesis in pre-malignant conditions.

Authors:  Marius Raica; Anca Maria Cimpean; Domenico Ribatti
Journal:  Eur J Cancer       Date:  2009-05-04       Impact factor: 9.162

9.  Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT.

Authors:  Agnès J van de Wouw; Rob L H Jansen; Arjan W Griffioen; Harry F P Hillen
Journal:  Anticancer Res       Date:  2004 Jan-Feb       Impact factor: 2.480

10.  Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.

Authors:  Vasilis Karavasilis; Vasiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Haralambos Kalofonos; George Fountzilas; Theodore Fotsis; Nicholas Pavlidis
Journal:  BMC Cancer       Date:  2005-03-03       Impact factor: 4.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.